Gara Jalqabaatti › Myeloma Baay’ee › Ohio › Columbus
Qorannoo klinikaalii Myeloma Baay’ee Columbus, OH keessatti
Qorannoo 24 Myeloma Baay’ee f Columbus fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
Testing Teclistamab (TECVAYLI) in Combination With Iberdomide for Relapsed or Refractory Multiple Myeloma
Namoota walitti qabaa jiraSadarkaa 1
- Ohio State University Comprehensive Cancer Center, Columbus
A Clinical Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Gamunex in Participants With Secondary Antibody Deficiency Associated With Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma
Namoota walitti qabaa jiraSadarkaa 3
- Study Site 104, Columbus
A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma
Namoota walitti qabaa jiraSadarkaa 1/2
- The James Cancer Hospital and Solove Research Institute At Ohio State University, Columbus
Geriatric Assessment Guided Interventions to Accelerate Functional Recovery After CAR-T Therapy for Patients 60 Years and Older With B-cell Non-Hodgkin Lymphoma or Multiple Myeloma, GOCART Study
Namoota walitti qabaa jiraSadarkaa 2
- Ohio State University Medical Center Dept. of Internal Medicine, Division of Hematology, Columbus
A Study to Compare Linvoseltamab and Daratumumab Treatment in High-Risk Smoldering Multiple Myeloma (HR-SMM)
Namoota walitti qabaa jiraSadarkaa 3
- Ohio State University, Columbus
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
Namoota walitti qabaa jiraSadarkaa 3
- The Ohio State University- James Cancer Hospital, Columbus
- OhioHealth, Columbus
Collection of Tissue Samples for Cancer Research
Namoota walitti qabaa jiraQorannoo ilaalaa
- Ohio State University, Columbus
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
Namoota walitti qabaa jiraSadarkaa 2
- The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer Center, Columbus
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
Namoota walitti qabaa jiraSadarkaa 3
- Columbus Oncology and Hematology Associates Inc, Columbus
- Riverside Methodist Hospital, Columbus
- Grant Medical Center, Columbus
- fi 7 dabalataa
A Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or Refractory Systemic Light Chain Amyloidosis (AL Amyloidosis)
Namoota walitti qabaa jiraSadarkaa 1/2
- Ohio State University, Columbus
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
Namoota walitti qabaa jiraSadarkaa 3
- Research Site, Columbus
A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects
Namoota walitti qabaa jiraSadarkaa 1
- Ohio State University Comprehensive Cancer Center, Columbus
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations
Namoota walitti qabaa jiraSadarkaa 1/2
- The Ohio State University /ID# 271336, Columbus
A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Participants With Multiple Myeloma That is Resistant to Current Standard of Care Treatments
Namoota walitti qabaa jiraSadarkaa 1
- The Ohio State University James Cancer Hospital, Columbus
Infliximab for Cytokine Release Syndrome Prophylaxis During Teclistamab or Talquetamab Therapy in Patients With Relapsed or Refractory Myeloma
Namoota walitti qabaa jiraSadarkaa 2
- Ohio State University Comprehensive Cancer Center, Columbus
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation
Namoota walitti qabaa jiraSadarkaa 3
- Ohio State Medical Center, James Cancer Center, Columbus
- Ohio Health Research Institute, Columbus
Frontline T-cell Engager vs Autologous Stem Cell Transplant (ASCT) and Measurable Residual Disease (MRD)-Guided Sequential Intensification thERapy in Multiple Myeloma
Namoota walitti qabaa jiraSadarkaa 2
- The Ohio State University- The James Cancer Hospital and Solove Research Institute, Columbus
Isa-Rd for Frail and/or Much Older Patients With Newly Diagnosed Multiple Myeloma
Namoota walitti qabaa jiraSadarkaa 2
- The Ohio State University Comprehensive Cancer Center, Columbus
A Cognitive Training Intervention for Improving Cognitive and Neurological Outcomes in Patients Undergoing Treatment for Relapsed or Refractory Multiple Myeloma or B-cell Non-Hodgkin Lymphoma
Namoota walitti qabaa jira
- Ohio State University Comprehensive Cancer Center, Columbus
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
Namoota walitti qabaa jiraSadarkaa 1
- The Ohio State University, Columbus
A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
Namoota walitti qabaa jiraSadarkaa 3
- GSK Investigational Site, Columbus
Phase 1/2 Study of Linvoseltamab in Adult Patients With Relapsed or Refractory Multiple Myeloma
Namoota walitti qabaa jiraSadarkaa 1/2
- Ohio State University James Cancer Hospital, Columbus
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Namoota walitti qabaa jiraSadarkaa 1/2
- The Ohio State University Comprehensive Cancer Center, Columbus
Ohio State University Multiple Myeloma and Amyloidosis Data Registry and Sample Resource
Namoota walitti qabaa jiraQorannoo ilaalaa
- Ohio State University Medical Center, Columbus
Qorannoo Myeloma Baay’ee magaalota biroo keessatti
- New York City, NYQorannoo 60
- Boston, MAQorannoo 42
- Atlanta, GAQorannoo 42
- Houston, TXQorannoo 38
- Durham, NCQorannoo 37
- Nashville, TNQorannoo 32
- Denver, COQorannoo 27
- Rochester, MNQorannoo 24
- St. Louis, MOQorannoo 24
- Baldwin Park, CAQorannoo 23
- Edison, NJQorannoo 22
- Chicago, ILQorannoo 22
Qorannoo biroo Columbus keessatti
- Kansara Qara'a Non-Small CellQorannoo 57
- Saree OljooQorannoo 40
- Kansarii OvariiQorannoo 39
- Saree (Gosoota Hunda)Qorannoo 38
- Dhibee QaraQorannoo 37
- Leukemia Myeloidii HamaaQorannoo 35
- Luukemiya Limfoositiikii KeessummaaQorannoo 28
- Kansara MetastatikiiQorannoo 27
- Kansa EndometiriyaaliiQorannoo 25
- Kansarii ProstateQorannoo 24
- Kansarii ColorectalQorannoo 24
- MelanomaQorannoo 21
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.